— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Molecular basis for neurodegeneration in Ataxia telangiectasia
An upcoming paper from Dr David Wassarman (University of Wisconsin School of Medicine and Public Health) in the 1 May issue of G and D lends new insight into the pathogenesis of neurodegeneration in Ataxia telangiectasia.
Ataxia telangiectasia (A-T) is a rare, genetic immunodeficiency disease that affects multiple organ systems and is characterised by neurodegeneration and cancer predisposition. A-T is caused by recessive mutations in the ataxia telangiectasia mutated (ATM) gene.
While existing animal models have established how ATM mutations contribute to genomic instability and cancer susceptibility, Dr Wassarman's paper reveals how ATM mutations cause neurodegeneration.
The scientists generated a Drosophila model of A-T, in which neurodeneneration occurs in the absence of induced DNA damage - as it does in human A-T patients. Thus, Dr Wassarman's model most faithfully recapitulates neurodegeneration associated with the human disease.
Using this model, Dr Wassarman and colleagues determined ATM functions normally to prevent neurones from re-entering the cell cycle.
'At the end of the day, ATM-dependent arrest of cell growth is critical for both neurone function and tumour suppression,' explains Dr Wassarman. Furthermore, he is excited by the findings, as they 'point to possible therapeutic potential of CDC25 and other cell cycle inhibitors' to treat A-T as well as other neurodegenerative disorders.
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Secrets of cellular signalling shed light on novel cancer stem cell therapies
Needle-size device created to track tumours, radiation dose
Long-term data show vertebroplasty for osteoporotic spinal fractures provides dramatic pain relief
Octogenarians do as well as younger patients with Interventional Radiology arterial procedures